Below are the most recent publications written about "Patients" by people in Profiles.
-
Bardoczi JB, Rossen M, Eugster N, Agoritsas T, Gencer B, Rodondi N. [For which patients do the latest lipid lowering treatments reduce cardiovascular events?] Rev Med Suisse. 2024 Mar 06; 20(864):472-479.
-
Patel J, Yao L, Vina E, Fleece D, Arundathi J, Caricchio R, Wu H. Phenotype Systemic Lupus Erythematosus Patients from EPIC Cosmos. Stud Health Technol Inform. 2024 Jan 25; 310:159-163.
-
Pimentel CB, Pimentel MPT, Hartmann CW. Medical safety huddles to engage frontline physicians in patient safety: calling physicians back to the table. BMJ Qual Saf. 2023 12 14; 33(1):7-9.
-
Lek A, Keeler A, Flotte TR. Death after High-Dose rAAV9 Gene Therapy in a Patient with Duchenne's Muscular Dystrophy. Reply. N Engl J Med. 2023 12 07; 389(23):2211.
-
Flannery RB, Flannery GJ. Characteristics of International Assaultive Psychiatric Patients: Review of Published Findings, 2017-2022. Psychiatr Q. 2023 Dec; 94(4):559-568.
-
Maher TM, Assassi S, Azuma A, Cottin V, Hoffmann-Vold AM, Kreuter M, Oldham JM, Richeldi L, Valenzuela C, Wijsenbeek MS, Coeck C, Schlecker C, Voss F, Wachtlin D, Martinez FJ. Design of a phase III, double-blind, randomised, placebo-controlled trial of BI 1015550 in patients with progressive pulmonary fibrosis (FIBRONEER-ILD). BMJ Open Respir Res. 2023 09; 10(1).
-
Richeldi L, Azuma A, Cottin V, Kreuter M, Maher TM, Martinez FJ, Oldham JM, Valenzuela C, Gordat M, Liu Y, Stowasser S, Zoz DF, Wijsenbeek MS. Design of a phase III, double-blind, randomised, placebo-controlled trial of BI 1015550 in patients with idiopathic pulmonary fibrosis (FIBRONEER-IPF). BMJ Open Respir Res. 2023 08; 10(1).
-
Huff NR, Chimowitz H, DelPico MA, Gleason KT, Nanavati JD, Smulowitz P, Isbell LM. The consequences of emotionally evocative patient behaviors on emergency nurses' patient assessments and handoffs: An experimental study using simulated patient cases. Int J Nurs Stud. 2023 Jul; 143:104507.
-
O'Neil MM, Johnson RA, C?rdova D, Pryor J, Pinals DA. A legal dispute resolution intervention for patients with substance use disorders: a study protocol for a randomized controlled trial. BMC Public Health. 2023 03 06; 23(1):435.
-
Chiu DT, Stenson BA, Alghamdi M, Antkowiak PS, Sanchez LD. The association between day of arrival, time of arrival, daily volume and the rate of patients that "left without being seen". Am J Emerg Med. 2023 05; 67:24-28.